Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/22761
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2021-11-22T12:50:06Z | - |
dc.date.available | 2021-11-22T12:50:06Z | - |
dc.date.issued | 2006 | - |
dc.identifier.citation | Başkan, E. B. vd. (2006). ''A case of epidermodysplasia verruciformis associated with squamous cell carcinoma and Bowen's disease: A therapeutic challenge''. Journal of Dermatological Treatment, 17(3), 179-183. | en_US |
dc.identifier.issn | 0954-6634 | - |
dc.identifier.issn | 1471-1753 | - |
dc.identifier.uri | https://doi.org/10.1080/09546630600788844 | - |
dc.identifier.uri | https://www.tandfonline.com/doi/full/10.1080/09546630600788844 | - |
dc.identifier.uri | http://hdl.handle.net/11452/22761 | - |
dc.description.abstract | Epidermodysplasia verruciformis (EV) is a very rare and chronic disease characterized by a susceptibility to cutaneous infections by a group of phylogenetically related human papillomavirus (HPV) types. We present here a 52-year-old man previously diagnosed and treated as squamous cell carcinoma but also found to have epidermodysplasia verruciformis lesions in association with Bowen's disease. The patient was effectively treated with a combination of interferon therapy (6 million units, twice a week) and topical imiquimod for Bowen's disease (five times a week). We conclude that topical imiquimod is very effective in the treatment of Bowen's disease and may be combined with systemic interferon therapy in rare cases with multiple vivid presentations of HPV infections. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Taylor & Francis | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Dermatology | en_US |
dc.subject | Squamous cell carcinoma | en_US |
dc.subject | Interferon alpha | en_US |
dc.subject | Imiquimod | en_US |
dc.subject | Epidermodysplasia verruciformis | en_US |
dc.subject | Bowen's disease | en_US |
dc.subject | Human papillomaviruses | en_US |
dc.subject | DNA | en_US |
dc.subject | Imiquimod 5-percent cream | en_US |
dc.subject | Acitretin | en_US |
dc.subject | Immunodeficiency | en_US |
dc.subject | Combination | en_US |
dc.subject | Immunotherapy | en_US |
dc.subject.mesh | Skin neoplasms | en_US |
dc.subject.mesh | Scalp | en_US |
dc.subject.mesh | Middle aged | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Interferons | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Epidermodysplasia verruciformis | en_US |
dc.subject.mesh | Drug therapy, combination | en_US |
dc.subject.mesh | Diagnosis, differential | en_US |
dc.subject.mesh | Carcinoma, squamous cell | en_US |
dc.subject.mesh | Bowen's disease | en_US |
dc.subject.mesh | Antineoplastic agents | en_US |
dc.subject.mesh | Aminoquinolines | en_US |
dc.subject.mesh | Administration, cutaneous | en_US |
dc.title | A case of epidermodysplasia verruciformis associated with squamous cell carcinoma and Bowen's disease: A therapeutic challenge | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000239194900012 | tr_TR |
dc.identifier.scopus | 2-s2.0-33746608141 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Dermatoloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Patoloji Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-0144-3263 | tr_TR |
dc.identifier.startpage | 179 | tr_TR |
dc.identifier.endpage | 183 | tr_TR |
dc.identifier.volume | 17 | tr_TR |
dc.identifier.issue | 3 | tr_TR |
dc.relation.journal | Journal of Dermatological Treatment | en_US |
dc.contributor.buuauthor | Başkan, Emel Bülbül | - |
dc.contributor.buuauthor | Tunalı, Şükran | - |
dc.contributor.buuauthor | Adım, Saduman Balaban | - |
dc.contributor.buuauthor | Turan, Ayşegül | - |
dc.contributor.buuauthor | Toker, Semra | - |
dc.contributor.researcherid | AAH-1388-2021 | tr_TR |
dc.identifier.pubmed | 16854762 | tr_TR |
dc.subject.wos | Dermatology | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | Pubmed | en_US |
dc.contributor.scopusid | 6602518817 | tr_TR |
dc.contributor.scopusid | 7004191748 | tr_TR |
dc.contributor.scopusid | 15730076300 | tr_TR |
dc.contributor.scopusid | 14055302400 | tr_TR |
dc.contributor.scopusid | 14054750900 | tr_TR |
dc.subject.scopus | Epidermodysplasia Verruciformis; Betapapillomavirus; Skin Neoplasms | en_US |
dc.subject.emtree | Imiquimod | en_US |
dc.subject.emtree | Alpha interferon | en_US |
dc.subject.emtree | Wart virus | en_US |
dc.subject.emtree | Virus infection | en_US |
dc.subject.emtree | Symptom | en_US |
dc.subject.emtree | Squamous cell carcinoma | en_US |
dc.subject.emtree | Actinic keratosis | en_US |
dc.subject.emtree | Skin biopsy | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Punch biopsy | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Phylogeny | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Infection sensitivity | en_US |
dc.subject.emtree | Human tissue | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Histopatholog | en_US |
dc.subject.emtree | Epidermodysplasia verruciformis | en_US |
dc.subject.emtree | Drug efficacy | en_US |
dc.subject.emtree | Drug effect | en_US |
dc.subject.emtree | Disease association | en_US |
dc.subject.emtree | Clinical feature | en_US |
dc.subject.emtree | Case report | en_US |
dc.subject.emtree | Bowen disease | en_US |
dc.subject.emtree | Article | en_US |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.